{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:41:26Z","timestamp":1785534086389,"version":"3.56.0"},"reference-count":0,"publisher":"Instituto Nacional de Salud Publica","issue":"4 (jul-ago)","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Salud Publica Mex"],"abstract":"<jats:p>Objetivo. Identificar los medicamentos con potencial psicoactivo y uso indebido en la poblaci\u00f3n mexicana. Material y m\u00e9todos. Se utilizaron datos de la Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco 2025, la muestra incluy\u00f3 a 555 personas que reportaron uso indebido de medicamentos psicoactivos alguna vez en la vida, y representan a 2.4 millones de personas. Resultados. El medicamento m\u00e1s reportado fue el tramadol (86.8%), sustancia clasificada como opioide. Le siguieron el clonazepam (76.5%) y el diazepam (15.1%), ambos tranquilizantes. En tercer lugar, se encontr\u00f3 el metilfenidato (37.8%), considerado un estimulante de uso m\u00e9dico. Otros medicamentos fueron mencionados con muy baja frecuencia, entre ellos morfina, fentanilo, alprazolam, flunitrazepam, clobenzorex, fentermina, anfetamina, fenobarbital y pregabalina. Conclusi\u00f3n. La regulaci\u00f3n del uso indebido de medicamentos psicoactivos en M\u00e9xico requiere fortalecer los mecanismos de coordinaci\u00f3n, supervisi\u00f3n y vigilancia, as\u00ed como promover estrategias de prevenci\u00f3n e impulsar la educaci\u00f3n en salud.\n\n\u00a0\n\n\u00a0<\/jats:p>","DOI":"10.21149\/18350","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:24:26Z","timestamp":1785525866000},"page":"307-313","source":"Crossref","is-referenced-by-count":0,"title":["Uso indebido de medicamentos psicoactivos en M\u00e9xico: resultados de la Encodat 2025"],"prefix":"10.21149","volume":"68","author":[{"given":"Miguel \u00c1ngel","family":"L\u00f3pez-Brambila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Fleiz-Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Lorenia","family":"Cruz-Mart\u00edn del Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Bencomo","family":"Cruz-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonatiuh","family":"Barrientos-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Copytzy","family":"Cruz-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayely Vianey","family":"Salazar-Trujillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8786","published-online":{"date-parts":[[2026,7,30]]},"container-title":["Salud P\u00fablica de M\u00e9xico"],"original-title":[],"link":[{"URL":"https:\/\/saludpublica.mx\/index.php\/spm\/article\/download\/18350\/12829","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/saludpublica.mx\/index.php\/spm\/article\/download\/18350\/12829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:24:27Z","timestamp":1785525867000},"score":1,"resource":{"primary":{"URL":"https:\/\/saludpublica.mx\/index.php\/spm\/article\/view\/18350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":0,"journal-issue":{"issue":"4 (jul-ago)","published-online":{"date-parts":[[2026,7,30]]}},"URL":"https:\/\/doi.org\/10.21149\/18350","relation":{},"ISSN":["1606-7916","0036-3634"],"issn-type":[{"value":"1606-7916","type":"electronic"},{"value":"0036-3634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,30]]}}}